BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma

Clinical trial NCT05376345 · TERMINATED

Trial details

NCT number: NCT05376345
Sponsor: Shanghai Changzheng Hospital
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Multiple Myeloma

Start date: 2022-09-01
Primary completion: 2025-05-27
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.